InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Summit Partners Growth Equity Fund IX-A, L.P.. Director active across 2 companies, notably LifeStance Health Group, Inc.. Cumulatively, 3 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €56.2m. Activity tracked since 14 June 2021. The latest transaction was disclosed on 24 May 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Summit Partners Growth Equity Fund IX-A, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,802,345 shares@ US$5.89100.0% of flowCommon StockSEC:0000950170-24-066078:0
1,140,704 shares@ US$17.0145.9% of flowCommon StockSEC:0001179110-21-007118:0
1,368,844 shares@ US$17.0154.1% of flowCommon StockSEC:0001179110-21-006787:0
3 of 3 declarations
About Summit Partners Growth Equity Fund IX-A, L.P.
Summit Partners Growth Equity Fund IX-A, L.P. is a declarant linked to LifeStance Health Group, Inc. on XNAS. The declarant has filed 5 filings in total, and in the recent filings we hold, the transactions are sales, with EUR 0 of buys and EUR 91655760 of sells between 2021-06-16 and 2024-05-29.
